Back
Editas Medicine Stock Price Chart

Your Summer Trading Shortcut
Try it free today.
Buy
56
EDIT
Editas Medicine
Last Price:
$2.57
Seasonality Move:
-11.1%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.3 | Buy |
20-day SMA: | 2.17 | Buy |
50-day SMA: | 1.81 | Buy |
200-day SMA: | 2.02 | Buy |
8-day EMA: | 2.34 | Buy |
20-day EMA: | 2.17 | Buy |
50-day EMA: | 1.82 | Buy |
200-day EMA: | 0.89 | Buy |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 67.1 | Buy |
Chaikin Money Flow: | -957413 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.86 - 2.32) | Buy |
Bollinger Bands (100): | (1.23 - 2.03) | Buy |
Editas Medicine Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 2.57 while EDIT 8-day simple moving average is 2.30, which is a Buy signal.
-
The stock price of EDIT is 2.57 while Editas Medicine 20-day SMA is 2.17, which makes it a Buy.
-
Editas Medicine 50-day simple moving average is 1.81 while EDIT share price is 2.57, making it a Buy technically.
-
EDIT stock price is 2.57 and Editas Medicine 200-day simple moving average is 2.02, creating a Buy signal.
EDIT Technical Analysis vs Fundamental Analysis
Buy
56
Editas Medicine (EDIT)
is a Buy
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a BuyThe current Editas Medicine [EDIT] share price is $2.57. The Score for EDIT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Editas Medicine Stock Info
Market Cap:
215.1M
Price in USD:
2.57
Share Volume:
1.9M
Editas Medicine 52-Week Range
52-Week High:
6.05
52-Week Low:
0.91
Buy
56
Editas Medicine (EDIT)
is a Buy
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 2.57 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is not overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 2.57 while EDIT 8-day exponential moving average is 2.34, which is a Buy signal.
-
The stock price of EDIT is 2.57 while Editas Medicine 20-day EMA is 2.17, which makes it a Buy.
-
Editas Medicine 50-day exponential moving average is 1.82 while EDIT share price is 2.57, making it a Buy technically.
-
EDIT stock price is 2.57 and Editas Medicine 200-day simple moving average is 0.89, creating a Buy signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.07 per share, an increase this year of $0.77 per share, and an increase next year of $0.78 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Editas Medicine is a Buy
-
Editas Medicine Relative Strength Index (RSI) is 67.1, which suggest Editas Medicine is overbought
-
The Bollinger Bands (25) for Editas Medicine is (1.86 - 2.32), which suggest Editas Medicine is a Buy
-
The Bollinger Bands (100) for Editas Medicine is (1.23 - 2.03), which suggest Editas Medicine is a Buy
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.